Bioharmony Therapeutics, Inc.
https://www.bioharmonytherapeutics.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Bioharmony Therapeutics, Inc.
Deal Watch: Celgene Makes Alliances With Kyn, Obsidian After Bristol Buyout
Bookmark
-
Analysis
Just two weeks after agreeing on a merger with Bristol, Celgene is back at its own deal-making, signing cancer-focused R&D pacts with Kyn and Obsidian. Boehringer and Bioharmony collaborate on novel therapies for hospital-acquired infections, while Sanofi teams with Biomunex on bi- and multi-specific antibodies.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
Advertisement
Advertisement